A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease
机构:[1]Department of Nephrology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.[2]Department of Nephrology, Guangdong General Hospital, Guangzhou, 510030, China.内科科室肾内科广东省人民医院[3]Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 China.[4]Department of Nephrology, The Fifth Affiliated Hospital of Fudan University, Shanghai, 200240, China.[5]Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.[6]Department of Nephrology, The First Affiliated Hospital of Shanghai Jiao Tong University, Shanghai, 200080, China.[7]Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.[8]Department of Nephrology, Department of Nephrology, Inner Mongolia People’s Hospital, Inner Mongolia, China.[9]Department of Nephrology, Shanghai Yangpu Hospital, Tongji University, Shanghai, 200090, China.[10]Department of Nephrology, PLA Navy General Hospital, Beijing, 100048, China.[11]Department of Nephrology, Beijing Anzhen Hospital Capital Medical University, Beijing, 100029, China.临床科室肾内科首都医科大学附属安贞医院[12]Department of Nephrology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.[13]Department of Nephrology, Shanghai Construction Group Hospital, Shanghai, 200083, China.[14]Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.[15]Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.[16]Department of Nephrology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.[17]Department of Nephrology, Jiangsu Province Hospital, Nanjing, 210029, China.内科系统肾内科江苏省人民医院[18]Department of Nephrology, Fujian Provincial Hospital, Fuzhou, 350001, China.[19]Department of Nephrology, Jiangsu Taizhou People’s Hospital, Taizhou, 225300, China.[20]Department of Nephrology, Sichuan Provincial People’s Hospital, Sichuan, 610072, China.非手术科室肾内科四川省人民医院[21]Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.华中科技大学同济医学院附属同济医院[22]Department of Nephrology, Union Hospital, Huazhong University of Science and Technology, Wuhan, 430022, China
Limited data are available on epidemiology and drug use in Chinese hypertensive patients with chronic kidney disease (CKD). We determined the prevalence; awareness, treatment, and control rates of hypertension; anti-hypertensive use, expenditure pattern; and factors associated with hypertension prevalence and control in Chinese patients with CKD. This was one of the largest cross-sectional surveys that enrolled 6079 CKD participants (mean age, 51.0 +/- 16.37 years) with or without hypertension from 22 centres across China. The prevalence, awareness, and treatment rates were 71.2%, 95.4%, and 93.7%, respectively. Control rates 1 and 2 (Blood pressure, BP < 140/90 and < 130/80 mmHg) were 41.1% and 15.0%, respectively. Patients were treated mostly with monotherapy (37.7%) or 2-drug antihypertensive combination (38.7%). Factors associated with prevalence of hypertension included age; smoking; body mass index; physical exercise; family history of hypertension; hyperuricaemia; and CKD. Control rate was associated with CKD stage, BP monitoring at home, and use of drug combinations. Despite high rates of awareness and treatment, the control rates are low. CKD stages 4 and 5 adversely
基金:
The main funding
for this study was provided by the Bayer HealthCare Pharmaceuticals, Research on hypertensive nephropathy
and ischaemic kidney diseases National key technology R&D programme (12-5) (Study No. 2011BAI10B00
(2011BAI10B06). The study was partially funded by Beijing Novartis Pharma.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|2 区综合性期刊
小类|2 区综合性期刊
最新[2023]版:
大类|2 区综合性期刊
小类|2 区综合性期刊
第一作者:
第一作者机构:[1]Department of Nephrology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
通讯作者:
通讯机构:[1]Department of Nephrology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
推荐引用方式(GB/T 7714):
Wen Zhang,Wei Shi,Zhangsuo Liu,et al.A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease[J].SCIENTIFIC REPORTS.2016,6:-.doi:10.1038/srep38768.
APA:
Wen Zhang,Wei Shi,Zhangsuo Liu,Yong Gu,Qinkai Chen...&Nan Chen.(2016).A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease.SCIENTIFIC REPORTS,6,
MLA:
Wen Zhang,et al."A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease".SCIENTIFIC REPORTS 6.(2016):-